Adverse events, compliance, and changes in therapy

Current Hypertension Reports

Volumn 3, Issue 6, 2001, Pages 488-492

  Düsing, Rainer ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ATTITUDE TO HEALTH; HUMAN; HYPERTENSION; PATIENT COMPLIANCE; REVIEW; TREATMENT OUTCOME;

ANTIHYPERTENSIVE AGENTS; ATTITUDE TO HEALTH; HUMANS; HYPERTENSION; PATIENT COMPLIANCE; TREATMENT OUTCOME;

EID: 0035656230     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-001-0011-0     Document Type: Article

References (22)

1. Haynes RB: Introduction. In Compliance in Health Care. Edited by: Haynes RB, Taylor DW, Sackett DL. Baltimore: The Johns Hopkins University Press; 1979:1-7.
2. Düsing R., Lottermoser K, Mengden T: Compliance with drug therapy - new answers to an old question. Nephrol Dial Transplant 2001, 16:1317-1321.
3. Kass MA, Zimmermann T, Yablonski M: Compliance to pilocarpine therapy [abstract]. Invest Ophthalmol 1977, 108:2.
4. Urquhardt J: The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet 1997, 32:345-356.
5. Métry J-M: Measuring compliance in clinical trials and ambulatory care. In Drug Regimen Compliance. Issues in Clinical Trials and Patient Management. Edited by: Métry J-M, Meyer UA. New York: John Wiley & Sons; 1999:1-22.
6. Urquhardt J: Role of patient compliance in clinical pharmacokinetics: review of recent research. Clin Pharmacokinet 1994, 27:202-215.
7. Urquhart J, Chevalley C: Impact of unrecognized dosing errors on the cost and effectiveness of pharmaceuticals. Drug Information J 1988, 22:363-378.
8. Feinstein A: On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990, 150:1377-1378.
9. Cramer JA, Scheyer RD, Mattson RH: Compliance declines between clinic visits. Arch Intern Med 1990, 150:1509-1510.
10. Düsing R., Weisser B, Mengden T., Vetter H: Changes in antihypertensive therapy - the role of adverse effects and compliance. Blood Pres 1998, 7:313-315.
11. Haynes RB: A critical review of the determinants of patient compliance with therapeutic regimens. In Compliance with Therapeutic Regimens. Edited by: Sackett DL, Haynes RB. Baltimore: Johns Hopkins University Press; 1976.
12. Jones JK, Gorkin L, Lian J.F., et al.: Discontinuation of and changes in treatment after start of new courses of antihypertensive drugs: a study of a United Kingdom population. BMJ 1995, 311:293-295.
13. Caro JJ, Salas M, Speckman J.L., et al.: Persistence with treatment for hypertension in actual practice. Can Med Assoc J 1999, 160:31-37.
14. Caro JJ, Speckman JL, Salas M, et al: Effect of initial drug choice on persistence with antihypertensive therapy. The importance of actual practice data. Can Med Assoc J 1999, 160:41-46.
15. Caro JJ: Stepped care for hypertension: are the assumptions valid? J Hypertens (Suppl) 1977:S35-S39.
16. Caro JJ, Speckman JL: Existing treatment strategies: does noncompliance make a difference. J Hertens (Suppl) 1998:S31-S34.
17. Monane M, Bohn R, Gurwitz J.H., et al.: The effects of initial drug choice and comorbidity on antihypertensive therapy compliance: results from a population-based study in the elderly. Am J Hypertens 1997, 10:697-704.
18. Bloom BS: Continuation of initial antihypertensive medication after 1 year of therapy. Clin Ther 1998, 20:671-681.
19. Rizzo JA, Simons WR: Variations in compliance among hypertensive patients by drug class: implications for health care costs. Clin Ther 1997, 19:1447-1457.
20. Düsing R., Lottermoser K, Mengden T., Vetter H: Compliance with antihypertensive therapy. Comparison of losartan, amlodipine and metoprolol in an open prospective trial. Am J Hypertens 2001, 14:98A.
21. Moore MA, Edelman JM, Gazdick L.P., et al.: Choice of initial anti-hypertensive medication may influence the extent to which patients stay on therapy: a community-based study of a losar-tan-based regimen vs. usual care. High Blood Press 1998, 7:1-12.
22. Toyoshima H, Takahashi K, Akera T: The impact of side effects on hypertension management: a Japanese survey. Clin Ther 1997, 19:1424-1425.